ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
PO Box 28,
South Australia 5007
Closed while relocating
1300 128 339
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
The Minister for Health on MCS issues
Saturday 7 June 2008
Here’s a response from the South Australan Minister for Health, Hon John Hill MP (pictured), to Sandra Kanck MLC on two issues: guidelines for access to public buildings for chemically sensitive persons; and the draft Hospital Guidelines for MCS patients.
Let us know if you’ve come across the first document being used anywhere. We know little about it ourselves.
Hon John Hill MP
28 MAR 2008
Hon Sandra Kanck MLC
Thank you for your letter of 27 February 2008 about the status of some issues related to Multiple Chemical Sensitivity (MCS).
A checklist to ensure access to public buildings for people with chemical sensitivity has been in operation for over a year. This checklist was approved by Senior Management Council (the Council of Government Department Chief Executives) and is used to identify potential barriers to access, including chemical barriers, for people with disabilities and conditions such as MCS. All chemicals and chemical sources are reviewed, including cigarette smoke, building and renovation materials, pesticides, chemicals used in cleaning, and personal hygiene/fragrance chemicals.
With regard to hospital access by MCS patients, I am advised that a draft protocol has been developed by the Department of Health and has been approved for consultation with regional hospital executives and key professional and clinical staff. It is envisaged that their comments will be reviewed in light of what can be reasonably achieved to improve hospital access by MCS patients.
MINISTER FOR HEALTH
Here is a scan of the letter: